简体
简体中文
繁體中文

奥信天力 ABAC

等待开盘 10-17 09:30:00 美东时间

1.7632

0.000

0.00%

华盛通华盛通
立即下载
  • 最 高--
  • 今 开--
  • 成交量 0股
  • 最 低 --
  • 昨 收 1.7632
  • 总市值 2619.30万
  • 52周最高 3.39
  • 市盈率 --
  • 换手率 0.00%
  • 52周最低 0.85
  • 委 比 0.00%
  • 总股本 1485.54万
  • 历史最高 4.76
  • 量 比 0
  • 振 幅 0.00%
  • 历史最低 0.48
  • 每 手 1
  • 风险率 0.00%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Abacus Global Management Announces Upcoming Conference Participation

    Abacus Global Management will participate in ABS East 2025 on October 20–22, 2025, and the Piper Sandler Financial Services Conference on November 10–12, 2025, both in Miami, Florida. Key executives, including CEO Jay Jackson, CFO Bill McCauley, and Chief Capital Officer Elena Plesco, will attend to meet with investors. To schedule a meeting, contact the conference representatives or email ir@abacusgm.com.

    10-13 12:00

  • Abacus Global Management Joins Russell 2000® and 3000® Indexes

    Abacus Global Management was added to the Russell 2000 and Russell 3000 indexes effective September 22, 2025, as part of the 2025 Russell indexes reconstitution. This inclusion also places the company in the appropriate growth and value style indexes. Jay Jackson, CEO, stated that this milestone enhances Abacus's visibility and validates its ability to create value for shareholders. Russell indexes, managed by FTSE Russell, are widely used as ben...

    09-22 12:00

  • Abacus Global Management and Dynasty Financial Partners Announce Minority Investment

    Abacus Global Management has announced a minority investment in Dynasty Financial Partners, strengthening their years-long strategic partnership. This collaboration aims to support both companies' growth and expansion. Dynasty provides technology-enabled wealth management solutions for independent financial advisors, and Abacus leverages this to enhance its services and national reach. The investment underscores the thriving independent wealth ma...

    08-12 12:00

  • Kiora Pharmaceuticals GAAP EPS of -$0.54

    Kiora Pharmaceuticals press release (NASDAQ:KPRX): Q2 GAAP EPS of -$0.54. Ended the quarter with $20.7 million in cash, cash equivalents and short-term investments, along with $2.4 million in collabor...

    08-08 19:09

  • 五粮液再度参与APEC全球推介会,相聚世界、共酿“和美”

      6月30日,以“共筑亚太发展新愿景”为主题的2025年亚太经合组织(APEC)工商领导人峰会全球推介会(以下简称“推介会”)在北京举行。五粮液再度携手AP...

    07-02 16:05

  • Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

    Abacus Global Management announced an exchange offer and consent solicitation for its public and private placement warrants. Warrant holders can exchange each warrant for 0.23 shares of common stock, with a total of 4,743,381 shares available. The offer aims to simplify the capital structure and reduce dilution. Additionally, the company seeks consent to amend the warrant agreement to allow a 10% lower exchange ratio (0.207 shares) for remaining ...

    06-30 12:00

  • Kiora Grants Senju Option to Develop and Market Vision-Restoring Drug KIO-301 in Asia

    Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) ("Kiora" or the "Company") today announced it has granted Senju Pharmaceutical Co., Ltd. (Senju) an exclusive option to exercise rights to an exclusive development and

    06-03 19:05

  • 黄仁勋在华表态,中方回应

    4月28日,中国贸促会举行4月例行新闻发布会,发言人赵萍回答记者提问。 有记者提问,近期,应中国贸促会邀请,美国英伟达公司总裁兼首席执行官黄仁勋访华,并表示希...

    04-28 17:16

  • 黄仁勋希望继续与中国合作,中国贸促会回应

      4月28日,中国贸促会举行4月例行新闻发布会,发言人赵萍回答记者提问。   有记者提问,近期,应中国贸促会邀请,美国英伟达公司总裁兼首席执行官黄仁勋访华,并...

    04-28 15:03

  • 贸促会调查:75.3%的企业计划拓展新兴市场弥补对美出口减少份额

    中方的态度是明确的,中国开放的大门始终向包括美国企业在内的所有外资企业敞开。 面对特朗普政府所谓“对等关税”政策带来的不确定性,外贸企业有何反应及对策? 4月...

    04-28 14:40